Chemotherapy-induced neutropenia is a complication of cancer treatment that has many consequences for the patient. The incidence of death from neutropenic fevers and sepsis is estimated to be about 5% ...

Background The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on ...

A historical overview regarding the development and role of granulocyte colony-stimulating factors as prophylaxis for chemotherapy-induced neutropenia and recommendations for use. Lee Schwartzberg, MD ...

Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). We ...

Embase, Ovid MEDLINE, PubMed, Cochrane Database of Systematic Reviews, Cochrane Register of Controlled Trials, and conference proceedings were searched from 1946 to April 2016 for trials that reported ...

All 98 patients undergoing autologous PBPC transplantation with etoposide/G-CSF mobilization between December 1997 and June 2000 had their medical records, microbiologic data, and stem cell yields ...

Please provide your email address to receive an email when new articles are posted on . The use of levofloxacin for neutropenic prophylaxis is associated with an increased incidence of Streptococcus ...

We therefore conducted this open-label, nonrandomized clinical pilot study to evaluate the pharmacokinetic profile of oral levofloxacin and to study its effect on throat and bowel microflora in ...

The NICE guideline on neutropenic sepsis covers preventing, identifying and managing neutropenic sepsis in children, young people and adults receiving treatment for cancer in the community and in ...

In this study we observed that ciprofloxacin prophylaxis in high-risk neutropenic patients was associated with a decrease (and delay) in the occurrence of fever, bacteremia, and duration of antibiotic ...

Suggestions regarding when it is appropriate to initiate chemotherapy-induced neutropenia prophylaxis in patients with cancer and goals of therapy. Lee Schwartzberg, MD, FACP: It’s interesting that ...

A prospective national cohort study should be carried out to assess the incidence of suspected and proven neutropenic sepsis in patients having anticancer treatment. The incidence of suspected ...